MedTrace Logo

Knee Related Subchondral Bone Lesions Treated With IOBP

NCT05314608 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2022-12-05

No results posted yet for this study

Summary

The study will be a prospective, multicenter clinical study evaluating clinical and patient reported outcome measures of subjects receiving IOBP® surgical technique using Angel cPRP and BMA processing system to treat subchondral bone pathology (SBP).

Conditions

  • Subchondral Cyst

Interventions

COMBINATION_PRODUCT

IntraOsseous BioPlasty® (IOBP®) Surgical Technique into the knee

Injection of a biologic mixture (BMC and allograft) into the subchondral bone lesion

Sponsors & Collaborators

  • Arthrex, Inc.

    lead INDUSTRY

Principal Investigators

  • Adam Anz · Andrews Research and Education Foundation

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-17
Primary Completion
2027-05-17
Completion
2027-05-17
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05314608 on ClinicalTrials.gov